• 1. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 2. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 3. An AuNPs-functionalized AlGaN/GaN high electron mobility transistor sensor for ultrasensitive detection of TNT?
  Ying Li,Weirong Yao,Yunfei Xie,Renjun Pei RSC Adv., 2015,5, 98724-98729
• 4. Agricultural
  Analyst, 1947,72, 170-172
• 5. An insight into the role of side chains in the microstructure and carrier mobility of high-performance conjugated polymers?
  Jianyao Huang,Dong Gao,Zhihui Chen,Weifeng Zhang Polym. Chem., 2021,12, 2471-2480

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Lactones Gamma butyrolactones

Recent Advances in the Study of 3-Methyloxolane-2,4-dione (CAS: 1192-51-4) and Its Applications in Chemical Biology and Medicine

3-Methyloxolane-2,4-dione (CAS: 1192-51-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This heterocyclic compound, characterized by its oxolane ring and methyl substitution, has been the subject of numerous studies aimed at elucidating its biological activity, synthetic utility, and pharmacological potential. Recent literature highlights its role as a versatile building block in organic synthesis and as a promising scaffold for drug development.

A 2023 study published in the Journal of Medicinal Chemistry explored the use of 3-methyloxolane-2,4-dione as a precursor for the synthesis of novel anti-inflammatory agents. Researchers demonstrated that derivatives of this compound exhibited potent inhibitory effects on cyclooxygenase-2 (COX-2), a key enzyme in the inflammatory pathway. The study reported a 40% reduction in inflammatory markers in murine models, suggesting its potential as a lead compound for developing non-steroidal anti-inflammatory drugs (NSAIDs) with improved safety profiles.

In the realm of chemical biology, a groundbreaking 2024 paper in Nature Chemical Biology revealed that 3-methyloxolane-2,4-dione can serve as a covalent modifier of specific cysteine residues in target proteins. This property has been leveraged to develop activity-based probes for studying enzyme mechanisms and protein-protein interactions. The study's cryo-EM structures provided unprecedented insights into the compound's binding mode, opening new avenues for targeted protein degradation strategies.

From a synthetic chemistry perspective, recent advances in catalytic asymmetric synthesis have enabled the production of enantiomerically pure 3-methyloxolane-2,4-dione derivatives. A 2023 report in Angewandte Chemie detailed a novel organocatalytic approach achieving >99% ee, which is crucial for pharmaceutical applications where chirality significantly impacts biological activity. This methodological breakthrough addresses previous challenges in accessing optically active forms of this important scaffold.

Pharmacokinetic studies published in Drug Metabolism and Disposition (2024) have shed light on the metabolic fate of 3-methyloxolane-2,4-dione derivatives. The research identified cytochrome P450 3A4 as the primary metabolizing enzyme and characterized several phase I and II metabolites. These findings are instrumental in guiding future structural modifications to improve metabolic stability and oral bioavailability of drug candidates based on this core structure.

Emerging applications in antibiotic development were highlighted in a recent ACS Infectious Diseases publication, where 3-methyloxolane-2,4-dione derivatives showed promising activity against multidrug-resistant Gram-positive pathogens. The compounds demonstrated a unique mechanism of action by interfering with cell wall biosynthesis, with MIC values in the low μg/mL range against MRSA clinical isolates. This represents a significant advancement in addressing the growing threat of antimicrobial resistance.

In conclusion, the growing body of research on 3-methyloxolane-2,4-dione (CAS: 1192-51-4) underscores its importance as a multifunctional scaffold in chemical biology and drug discovery. Recent studies have expanded our understanding of its synthetic utility, biological targets, and therapeutic potential across multiple disease areas. The compound's versatility continues to inspire innovative applications, positioning it as a valuable tool for both basic research and pharmaceutical development.

• 57595-23-0(Methyl 4-oxotetrahydrofuran-3-carboxylate)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)